Dr. Baum will be a member of Pfizer’s Executive ... This FDA action converts the September 2021 accelerated approval of TIVDAK to a full approval. TIVDAK is the first anti NEW YORK & COPENHAGEN ...
the drugmaker has picked up a valuable reward from the FDA in the form of a priority review voucher (PRV). The agency doled out the PRV after determining that Pfizer's COVID-19 antiviral Paxlovid ...
The first-quarter 2024 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizer’s R&D pipeline can be found at www.pfizer.com.
The med was approved as a first-line PNH ... Tecvayli was approved by the FDA in 2022 as a RRMM treatment for patients who have received at least four prior lines of therapy, including a ...
Indian drugmaker Torrent Pharmaceuticals has agreed to acquire Heumann Pharma GmbH & Co Generica KG of Germany through its wholly-owned German affiliate, Torrent Pharma GmbH. Heumann Pharma Generics, ...